Impact of Tofacitinib on Fracture Risk in Rheumatoid Arthritis

被引：0
|
作者：
Hansen, Karen E. [1 ]
Mortezavi, Mahta [2 ]
Nagy, Edward [3 ]
Wang, Cunshan [4 ]
Connell, Carol A. [4 ]
Radi, Zaher [5 ]
Litman, Heather J. [6 ]
Adami, Giovanni [7 ]
Rossini, Maurizio [7 ]
机构：
[1] Univ Wisconsin, Rheumatol Div, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Inc, Groton, CT USA
[5] Pfizer Inc, Cambridge, MA USA
[6] CorEvitas LLC, Waltham, MA USA
[7] Univ Verona, Dept Med, Rheumatol Unit, Verona, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1431
引用
收藏
页码：2821 / 2824
页数：4
相关论文
共 50 条
  • [11] Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
    England, Bryant R.
    Pedro, Sofia
    Mikuls, Ted R.
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [12] Tofacitinib for Treatment of Rheumatoid Arthritis
    Rakieh, Chadi
    Conaghan, Philip G.
    ADVANCES IN THERAPY, 2013, 30 (08) : 713 - 726
  • [13] Tofacitinib: A Review in Rheumatoid Arthritis
    Dhillon, Sohita
    DRUGS, 2017, 77 (18) : 1987 - 2001
  • [14] Tofacitinib (Xeljanz) for Rheumatoid Arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1407): : 1 - 3
  • [15] Tofacitinib for the treatment of rheumatoid arthritis
    Zerbini, Cristiano A. F.
    Vannucci Lomonte, Andrea Barranjard
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (04) : 319 - 331
  • [16] Tofacitinib for Treatment of Rheumatoid Arthritis
    Chadi Rakieh
    Philip G. Conaghan
    Advances in Therapy, 2013, 30 : 713 - 726
  • [17] TOFACITINIB IN ADULT PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: BUDGET IMPACT ANALYSIS
    Pyadushkina, E.
    Derkach, E., V
    VALUE IN HEALTH, 2017, 20 (09) : A529 - A529
  • [18] BUDGET IMPACT MODEL OF INCLUSION OF TOFACITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN FRANCE
    Masia, C.
    Pignata, M.
    Granghaud, A.
    Ben Chaabane, H.
    Garassus, Huyghe C.
    Dubanchet, A.
    Roze, S.
    VALUE IN HEALTH, 2018, 21 : S291 - S291
  • [19] Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies
    Boyce, Eric G.
    Vyas, Deepti
    Rogan, Edward L.
    Valle-Oseguera, Cynthia S.
    O'Dell, Kate M.
    PATIENT-RELATED OUTCOME MEASURES, 2016, 7 : 1 - 12
  • [20] IMPACT OF TOFACITINIB ON LIPID METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REALWORLD STUDY
    Huang, H.
    Geng, Y.
    Fan, Y.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1336 - 1337
12345